MIRA INFORM REPORT

 

 

 

Report Date :

27.06.2008

 

IDENTIFICATION DETAILS

 

Name :

ADCOCK INGRAM LIMITED

 

 

Registered Office :

Plot No.49 (C and D), Bommasandra Industrial Area, Anekal Taluk, Bangalore – 560099, Karnataka

 

 

Country :

India

 

 

Date of Incorporation :

03.04.2007

 

 

Com. Reg. No.:

042361

 

 

CIN No.:

[Company Identification No.]

U24232KA2007PLC042361

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

BLRA10031A

 

 

PAN No.:

[Permanent Account No.]

AAGCA4343M

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturer of Pharmaceuticals Products

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

 

 

Status :

New Company

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Mr. Ravi Prakash, Accountant denied to part details without the knowledge of the inquirers.

 

This is a joint venture of Medreich Limited, Bangalore and Adcock Ingram Holding (Pty) Limited, Africa. Trade relations are fair. Nothing adverse reported.

 

The company can be considered for normal business dealings at usual trade terms and conditions.

 

 

INFORMATION DECLINED BY

 

Name :

Mr. Ravi Prakash

Designation :

Accountant

Date :

24.06.2008

 

 

LOCATIONS

 

Registered Office/ Factory :

Plot No.49 (C and D), Bommasandra Industrial Area, Anekal Taluk, Bangalore – 560099, Karnataka, India

Tel. No.:

91-80-25493334

Fax No.:

91-80-25474741

E-Mail :

cpb@ho.medreich.com

Website :

http://www.adcock.co.za

 

 

Corporate Office :

No.13, Tawakal Chancery, Cooks Town, Banaswadi, Bangalore – 560043, Karnataka, India

Tel No.:

91-80-41601451/ 2/ 3/

 

 

DIRECTORS

 

Name :

Mr. R. A. Williams

Designation :

Chairman

 

 

Name :

Mr. L. Philip

Designation :

Managing Director

 

 

Name :

Mr. Chillale Govindaraj

Designation :

Director

Address :

No.87, IV Block, 16-C Main, Kormangala, Bangalore – 560034, Karnataka, India

Date of Birth/Age :

04.07.1951

 

 

Name :

Mr. Chandanmal Pukhraj Bothra

Designation :

Nominee Director

Address :

14, 7th Cross, Jaibharathnagar, Bangalore – 560033, Karnataka, India

Date of Birth/Age :

20.07.1956

Date of Appointment :

03.04.2007

Nominee Company :

Medreich Limited

E-Mail :

cpb@ho.medreich.com

 

 

Name :

Mr. Pravin Vaidyanathan Iyer

Designation :

Nominee Director

Address :

C-204, Mantri Woodlands, Arekere Gate, Bannerghatta Main Road, Bangalore – 560076, Karnataka, India

Date of Birth/Age :

10.08.1967

Date of Appointment :

03.04.2007

Nominee Company :

Medreich Limited

E-Mail :

pi@ho.medreich.com

 

 

Name :

Mr. Muhammad Mahmood Bodhania

Designation :

Nominee Director

Address :

38, Faunce Road, Robertsham, Johannesburg 2091

Date of Birth/Age :

22.04.1968

Date of Appointment :

25.04.2007

Nominee Company :

Medreich Limited

E-Mail :

mbodhania@medreich.co.za

 

 

Name :

Mr. Mahendra Chibabhai

Designation :

Nominee Director

Address :

8228 Virgo Street, Extension 9, Lenasia 1820

Date of Birth/Age :

08.11.1955

Date of Appointment :

25.04.2007

Nominee Company :

Adcock Ingram Holding (Proprietary) Limited

E-Mail :

Mahendra.chibabhai@tigerbrands.com

 

 

Name :

Mr. Jonathan James Low

Designation :

Nominee Director

Address :

1830 Augustus Way, Dainfern Valley, fourways 2055

Date of Birth/Age :

11.11.1969

Date of Appointment :

25.04.2007

Nominee Company :

Adcock Ingram Holding (Proprietary) Limited

E-Mail :

jonathan.louw@tigerbrands.com

 

 

Name :

Mr. Daryl Brian Kronson

Designation :

Nominee Director

Address :

2 Cavaillon, 19 Gary Avenue, Morningside Manor, Sandton 2196

Date of Birth/Age :

05.12.1946

Date of Appointment :

25.04.2007

Nominee Company :

Adcock Ingram Holding (Proprietary) Limited

E-Mail :

daryl.kronson@tigerbrands.com

 

 

Directorship in Other

Company :

Synchron Research Services Private Limited

Director

U85110GJ1998PTC034181

 

 

KEY EXECUTIVES

 

Name :

Mr. P. S. Nortier

Designation :

Chief Executive

 

 

Name :

Mr. D. B. Kronson

Designation :

Finance Directors and Company Secretary

 

 

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

(As on 22.03.2007)

Names of Subscribers

 

No. of Shares

Subscribed

Mr. C. P. Bothra

 

49940

Mr. C. Govindraj

 

10

Dr. Ashwani Kumar

 

10

Mr. V. Madhusudhan

 

10

Mr. R. Kedareshwar

 

10

Mr. Rami Reddy G. V.

 

10

Mr. Dasari Ramesh

 

10

 

 

 

Total

 

50000

 

(As on 01.11.2007

Names of Allottee

 

No. of Shares

Allotted

Medreich Limited

 

19000000

Adcock Ingram Holding (Proprietary) Limited

 

19000000

 

 

 

Total

 

38000000

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Pharmaceuticals Products

 

 

GENERAL INFORMATION

 

Bankers :

  • State Bank of Hyderabad

Industrial Finance Branch, Richmond Bangalore – 560025, Karnataka, India

 

 

 

Banking Relations :

Satisfactory

 

 

Auditors :

Not Available

 

 

Associates/Subsidiaries :

Synchron Research Services Private Limited

U85110GJ1998PTC034181

 

 

CAPITAL STRUCTURE

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

40000000

Equity Shares

Rs.10/- each

Rs.400.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

 

Not Available

 

 

 

 

 

 

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

 

As the subject is a new company, No financial are available.

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Form 8:

 

Corporate identity number of the company

U24232KA2007PLC042361

Name of the company

ADCOCK INGRAM LIMITED

Address of the registered office or of the principal place of  business in India of the company

Plot No.49 (C and D), Bommasandra Industrial Area, Anekal Taluk, Bangalore – 560099, Karnataka, India

This form is for

Modification of Charges

Type of charge

Immovable Property

Particular of charge holder

State Bank of Hyderabad

Industrial Finance Branch, Richmond Bangalore – 560025, Karnataka, India

Ifb_bang@sbhyd.co.in

Nature of instrument creating charge

Equitable Mortgage by deposit of title deeds with State Bank of Hyderabad, IFB, Bangalore is created on the land Building of the company situated at Plot No.49 C and D, Bommasandra Industrial Area – Copy attached.

Date of instrument Creating the charge

08.01.2008

Amount secured by the charge

Rs.510.000 Millions

Brief of the principal terms an conditions and extent and operation of the charge

Rate of Interests:

On Rupee term loan of Rs.360.000 Millions, Interests rate is 1% below PLR with reset at the end of every 2nd year; The present effective rate being the 12% per annum on monthly rests.

 

On working capital: (PC/FUBD/ FUBP of Rs.120.000 Millions and Letters of Credit of Rs.30.000 Millions) The Interests rests is as per RBI Directions, presently the effective rate being the 10% per annum.

 

Terms of Repayment:

The term Loan is repayable in Quarterly Installments of Rs.18.000 Millions each, commencing from June 2008 and working capital is sanction for a year effect from 02.08.2007.

 

Margin:

For Working Capital : 25% on inventory and

For Term loan : 49% of the project cost.

 

Extent and Operation of Charge:

The term Loan and Working capital Assistance are secured by hypothecation of movable fixed assets and current assets and further secured by equitable mortgage by deposit of title deeds of the and building of the company.

Particulars of the property charged

Movable Fixed Assets ABD Stock of Raw Materials, Semi Finished Goods, Finished Goods and Stores and Immovable Properties Being the and Building of the company situated at Plot No.49 C and D, Bommasandra Industrial Area, Anekal Taluk, Bangalore, India

Particulars of the present modification

Repayment of term loan of Rs.360.000 Millions and the working Capital of Rs.150.000 Millions along with Interests costs etc., are further secured by charge on the land and Building of the company situated at Plot No.49 C and D Bommasandra Industrial Area, Anekal Taluk, Bangalore, India by created equitable mortgage by deposit of Title deeds with the Bank.

 

 

Website Details

 

Profile:

 

Subject part of the JSE listed Tiger Brands Group, is a South African pharmaceutical company. It is also the longest standing pharmaceutical company, with humble beginnings from a small pharmacy in Krugersdorp 116 years ago. The company has an extensive range of prescription, generic and OTC products and also provides life saving hospital equipment, diagnostic products and services.


To complement a full range of generics and prescription medicines across all therapeutic classes, Adcock Ingram recently launched a range of generic ARVs. These were developed in-house by a team of senior researchers at Adcock Ingram’s WHO approved Research site in Aeroton.

 

Subject first listed on the Johannesburg Stock Exchange in 1949, develops, manufactures and distributes over the counter medicines, branded prescription pharmaceuticals and generics, critical care hospital products and consumer personal care toiletry and household products. The group is also active in the vision care market, providing prescription lenses, spectacle frames and ophthalmic instruments. The group merged on 1st May 1996 with The Premier Pharmaceutical Company Limited (Prempharm). Fiscal 1997 is the first full year's reporting on the new merged entity. The group acquired Sterilab Services on 1 July 1999 and Lagap Pharmaceuticals Limited on 1 October 1999.

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.42.73

UK Pound

1

Rs.84.38

Euro

1

Rs.66.97

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions